Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PD-(L)1”

86 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 86 results

Testing effectiveness (Phase 2)UnknownNCT06118645
What this trial is testing

Cadonilimab+ Paclitaxel (Albumin-bound) Treat Advanced Gastric Adenocarcinoma With PD-(L)1 Inhibitors Resistance

Who this might be right for
Gastric Adenocarcinoma
China Medical University, China 40
Testing effectiveness (Phase 2)Study completedNCT04393753
What this trial is testing

Domatinostat in Combination With Avelumab in Patients With Advanced Merkel Cell Carcinoma Progressing on Anti-PD-(L)1

Who this might be right for
Merkel Cell Carcinoma
4SC AG 19
Testing effectiveness (Phase 2)WithdrawnNCT05234606
What this trial is testing

A Safety and Preliminary Efficacy Study of SBT6290 Alone and in Combination With PD-(L)1 Inhibitors in Select Advanced Solid Tumors

Who this might be right for
Urothelial CarcinomaTriple Negative Breast CancerNon-small Cell Lung Cancer+2 more
Silverback Therapeutics
Testing effectiveness (Phase 2)Study completedNCT06029127
What this trial is testing

Gimistotug (BGB-A445) in Combination With Other Investigational Agents in Participants With Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
BeiGene 35
Testing effectiveness (Phase 2)WithdrawnNCT06424717
What this trial is testing

Study of Avelumab and Tuvusertib in Participants With Advanced Urothelial Cancer That Has Progressed on Prior Anti-PD-(L)1 Therapy (JAVELIN DDRiver Bladder)

Who this might be right for
Urothelial Carcinoma
EMD Serono Research & Development Institute, Inc.
Testing effectiveness (Phase 2)Active Not RecruitingNCT05061134
What this trial is testing

Ceralasertib Monotherapy and Ceralasertib Plus Durvalumab in Patients With Melanoma and Resistance to PD-(L)1 Inhibition

Who this might be right for
Melanoma
AstraZeneca 194
Testing effectiveness (Phase 2)Active Not RecruitingNCT05662397
What this trial is testing

HST-1011 Given as Monotherapy and in Combination With an Anti-PD1 Antibody

Who this might be right for
Solid Tumor, AdultRelapsed CancerRefractory Cancer
HotSpot Therapeutics, Inc 77
Early research (Phase 1)Study completedNCT07210320
What this trial is testing

PK/PD Study of IN-001 Sublingual Spray in Healthy Adults

Who this might be right for
Food AllergyAnaphylaxisFood Hypersensitivity+1 more
Insignis Therapeutics, Inc. 32
Testing effectiveness (Phase 2)WithdrawnNCT05561491
What this trial is testing

ONCOS-102 in Combination With Other Novel Immune-therapies in Advanced Treatment-resistant Melanoma Patients

Who this might be right for
Melanoma
Targovax Oy
Not applicableLooking for participantsNCT06635954
What this trial is testing

A Prospective Real World Evidence Study (PROWES) for Concordance Rate of Blood-based 3D Genome Conformation Mapping (Episwitch CiRT®) to Identify Likelihood of Response and Actual Response Rates to PD-(L)-1 Checkpoint Inhibitors Across Multiple Oncological Indications.

Who this might be right for
CancerImmunotherapyPD-1+2 more
Oxford Biodynamics Inc. 2,000
Large-scale testing (Phase 3)Not Yet RecruitingNCT07768189
What this trial is testing

Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma

Who this might be right for
Oropharyngeal Carcinoma (OPC)
Corbus Pharmaceuticals Inc. 260
Not applicableUnknownNCT06194695
What this trial is testing

DEB-TACE, Lenvatinib and Anti-PD(L)1 Antibody as Conversion Therapy for Intrahepatic Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma Non-resectable
Ze-yang Ding, MD 100
Testing effectiveness (Phase 2)UnknownNCT05296603
What this trial is testing

Efficacy and Biomarker Explanation of IBI-322 Plus Lenvatinib on Extensive Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Hunan Province Tumor Hospital 83
Not applicableNot Yet RecruitingNCT07376512
What this trial is testing

Predicting Response to Anti-PD-1/PD-L1 Immunotherapy by Plasma Extracellular Vesicle Analysis

Who this might be right for
Non-Small Cell Lung CancerMelanoma (Skin Cancer)
Centre Georges Francois Leclerc 378
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06708455
What this trial is testing

Phase 2b of RAPA-201 Cell Therapy in Post-PD-(L)-1 Melanoma

Who this might be right for
Malignant Melanoma With MetastasisMalignant MelanomaMalignant Melanoma Stage IIIc+1 more
Rapa Therapeutics LLC 65
Not applicableUnknownNCT05117372
What this trial is testing

ANALYSIS OF INFLAMMATORY REACTIONS OBSERVED IN BRONCHOALVEOLAR LAVAGES (BALS)

Who this might be right for
Lung Cancer
Centre Chirurgical Marie Lannelongue 34
Testing effectiveness (Phase 2)Looking for participantsNCT07639450
What this trial is testing

N-3C01 Monotherapy and Combination With PD-(L)1 Inhibitors in Advanced Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumors
Hefei Xinzhu Biological Technology Co., Ltd. 114
Not applicableLooking for participantsNCT06876753
What this trial is testing

Regional Lymph Node Metastasis and Survival Outcomes in Advanced HCC

Who this might be right for
Hepatocellular Carcinoma (HCC)
Zhongda Hospital 300
Testing effectiveness (Phase 2)Active Not RecruitingNCT06056895
What this trial is testing

Triple Immune Checkpoint Inhibition for Advanced or Metastatic PD-(L)1 Refractory Merkel Cell Carcinoma

Who this might be right for
Unresectable Clinical Stage III Merkel Cell Carcinoma AJCC v8Clinical Stage IV Merkel Cell Carcinoma AJCC v8Merkel Cell Carcinoma
University of Washington 12
Large-scale testing (Phase 3)Looking for participantsNCT07166094
What this trial is testing

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

Who this might be right for
Endometrial CancerRecurrent or Progressive Endometrial Cancer
Genmab 660
Next Page